Revised Choi imaging criteria correlate with clinical outcomes in patients with metastatic renal cell carcinoma treated with sunitinib.

MLA

Thian, Yeeliang, et al. “Revised Choi Imaging Criteria Correlate with Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib.” Radiology, vol. 273, no. 2, Nov. 2014, pp. 452–61. EBSCOhost, https://doi.org/10.1148/radiol.14132702.

APA

Thian, Y., Gutzeit, A., Koh, D.-M., Fisher, R., Lote, H., Larkin, J., & Sohaib, A. (2014). Revised Choi imaging criteria correlate with clinical outcomes in patients with metastatic renal cell carcinoma treated with sunitinib. Radiology, 273(2), 452–461. https://doi.org/10.1148/radiol.14132702

Chicago

Thian, Yeeliang, Andreas Gutzeit, Dow-Mu Koh, Rosalie Fisher, Hazel Lote, James Larkin, and Aslam Sohaib. 2014. “Revised Choi Imaging Criteria Correlate with Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib.” Radiology 273 (2): 452–61. doi:10.1148/radiol.14132702.